Natixis’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $227K | Buy |
+12,200
| New | +$227K | ﹤0.01% | 761 |
|
2024
Q4 | – | Sell |
-12,200
| Closed | -$517K | – | 1170 |
|
2024
Q3 | $517K | Buy |
+12,200
| New | +$517K | ﹤0.01% | 620 |
|
2023
Q2 | – | Sell |
-18,151
| Closed | -$737K | – | 1136 |
|
2023
Q1 | $737K | Sell |
18,151
-542
| -3% | -$22K | 0.01% | 557 |
|
2022
Q4 | $840K | Sell |
18,693
-672
| -3% | -$30.2K | ﹤0.01% | 605 |
|
2022
Q3 | $968K | Sell |
19,365
-854
| -4% | -$42.7K | ﹤0.01% | 731 |
|
2022
Q2 | $1.2M | Buy |
+20,219
| New | +$1.2M | ﹤0.01% | 741 |
|